Giovanni Ceccarini, Baris Akinci, David Araujo-Vilar, Marianna Beghini, Rebecca J Brown, Juan Carrion Tudela, Valeria Corradin, Bruno Donadille, Jose Jerez Ruiz, Isabelle Jeru, Giovanna Lattanzi, Margherita Maffei, George David McIlroy, Estelle Nobécourt, Naca Perez de Tudela, Justin Rochford, Rebecca Sanders, Julia von Schnurbein, Daniel Tews, Marie-Christine Vantyghem, Camille Vatier, Corinne Vigouroux, Ferruccio Santini
Lipodystrophic syndromes are rare diseases affecting primarily the development or maintenance of the adipose tissue but are also distressing indirectly multiple organs and tissues, causing in most of the cases reduced life expectancy and quality of life. Lipodystrophy syndromes are multifaceted disorders caused by genetic mutations or autoimmune and iatrogenic mechanisms, many subtypes are now recognized and classified but the disease remains remarkably underdiagnosed. The European Consortium of Lipodystrophies (ECLip) was founded in 2014 as a non-profit network of European centers of excellence working in the field of lipodystrophies aiming at promoting international collaborations to increase basic scientific understanding and clinical management of these syndromes...
March 5, 2024: Annales D'endocrinologie